Marco L. Leung
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
74
Citations
2,542
Est. group size
~8
Recurring co-author estimate
Active years
17
Publishing since 2010
Marco L. Leung works in clinical genomics and molecular diagnostics, focusing on how genetic testing methods like exome and genome sequencing are used, validated, and reanalyzed to diagnose rare and undiagnosed diseases. His work also addresses laboratory practice issues such as testing standards, workforce training, and policy questions around regulation of genetic tests. Several papers describe discovery of specific gene variants linked to neurodevelopmental disorders and cancer predisposition.
Publication output has grown substantially over the last decade, rising from occasional papers in 2017-2019 to a steady output of roughly 10-13 papers per year since 2023.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Phenotype-Driven In Silico Proficiency Testing Represents a Viable Approach for Undiagnosed Disorders by Exome Sequencing
Archives of Pathology & Laboratory Medicine · 2026
- Correction: BRAF inhibitors suppress apoptosis through off-target inhibition of JNK signaling
eLife · 2026
- Biallelic inactivating variants in the chromatin remodeler DMAP1 cause a syndromic neurodevelopmental disorder
Journal of Clinical Investigation · 2026
- A primer on regulation of laboratory-developed testing procedures: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)
Genetics in Medicine · 2025
- Path to Health Equity and Improved Outcomes through Inclusive Sex and Gender Data Collection in Genomic Testing
Journal of Molecular Diagnostics · 2025
- Retaining Clinical Genomics Technologists in the Post–COVID-19 Era
Journal of Molecular Diagnostics · 2025
- Microarray-Based DNA Methylation Profiling
Journal of Molecular Diagnostics · 2024
- Monoallelic <i>de novo</i> variants in <i>DDX17</i> cause a neurodevelopmental disorder
Brain · 2024
- The challenges and opportunities of offering and integrating training in clinical molecular genetics and clinical cytogenetics: A survey of LGG Fellowship Program Directors
Genetics in Medicine Open · 2024
- Author Correction: TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs
Nature · 2024
- Counterpoint: Why the FDA Should Not Regulate Laboratory-Developed Tests
The Journal of Applied Laboratory Medicine · 2024
- Clinical Utility and Long-Term Feasibility of Exome and Genome Reanalysis: From the Perspectives of a Clinical Laboratory
The Journal of Applied Laboratory Medicine · 2024
- Multisite Verification of a Targeted <i>CFTR</i> Polymerase Chain Reaction/Capillary Electrophoresis Assay That Evaluates Pathogenic Variants Across Diverse Ethnic and Ancestral Groups
Archives of Pathology & Laboratory Medicine · 2024
- Exploring current challenges in the technologist workforce of clinical genomics laboratories
Genetics in Medicine Open · 2023
- Monoallelic <i>de novo</i> variants in <i>DDX17</i> cause a novel neurodevelopmental disorder
medRxiv · 2023
- Genetics in Medicine Open×13
- Journal of Molecular Diagnostics×6
- Genetics in Medicine×5
- The Journal of Applied Laboratory Medicine×3
- Neuro-Oncology Pediatrics×3
- Ying‐Chen Claire Hou
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Kristy Lee
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Danielle Mouhlas
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Daniel C. Koboldt
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Yassmine Akkari
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile